organigram
organigram · page 2
- Markets & Stocks
Jazz Fails Phase 3 Trial in Japan, BAT Set to See Growth From Cannabis Investment, & DanCann Pharma Reports First Profit
Jazz Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”JAZZ” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The pharmaceutical giant announced last week that its flagship cannabinoid treatment, Epidyolex, failed to pass its Phase 3 clinical trial in Japan.
- Uncategorized
Organigram Posts Strong Q3 Figures as Sales Pick Up in Home Market
Organigram has reported a 25% year-on-year increase in revenues over its third quarter as sales in its home market rebounded.
- Press releases
Organigram Invests in Sanity Group, a Leading German Cannabis Company
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its first significant strategic investment aimed at expanding its presence in the European cannabis market.
- Companies
Organigram Signs 2nd UK Supply Deal With Avida Medical
Canadian cannabis giant Organigram has announced a new three-year supply deal in the UK as it continues to focus efforts on international expansion.
- Uncategorized
Organigram’s Q2 Figures Hit By Lower International Sales
As earnings season gets into full swing, Canada’s Organigram has become the latest major cannabis operator to publish its financial performance figures.
- Uncategorized
Hopes Of Tax Relief For Canadian Cannabis Industry Dashed As Budget Reveals No Changes
Hopes of tax relief for Canada’s cannabis industry were derailed yesterday as the country’s Federal Budget 2024 revealed excise taxes would not be changed.
- Uncategorized
Canada Set To Make Major Changes To Cannabis Excise Tax
Canada’s House of Commons Standing Committee on Finance has recommended a change in how cannabis is taxed.
- Uncategorized
Organigram Announces ‘Transformative’ C$124m Investment From Tobacco Giant BAT
Canadian cannabis producer Organigram has announced a further major investment from tobacco giant British American Tobacco (BAT).
- Companies
Organigram To Enter UK Market For The First Time As It Signs New Supply Deal With 4C Labs
Canadian cannabis producer Organigram is set to bring its products to the UK’s medical cannabis market for the first time amid a new tie-up with 4C Labs.
- Uncategorized
Organigram Blames ‘THC Inflation’ For Growing Losses and Falling Revenues in Q3
Canadian cannabis cultivator Organigram Holdings published its Q3 earnings last week, reporting falling revenues and a net loss of $213.5m.
- Uncategorized
Update on Organigram’s quarterly financials
BofC Live is a podcast from Business of Cannabis. Delivering cannabis news and exploring the companies, brands, people, and trends driving the cannabis industry.
- Your #1 Podcast on Cannabis News
How to gain market share in a crowded and competitive market
On this episode of BofC Live, we connect with Beena Goldenberg, CEO of Organigram.
